PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26364610-3	2016	Since the HSP90 inhibitor 17-allylamino-demethoxygeldanamycin (17AAG) is developed in clinics, we explored here its ability to control intestinal acute GvHD in vivo in two mouse GvHD models (C57BL/6 BALB/c and FVB/N Lgr5-eGFP), ex vivo in intestine organoids and in vitro in intestinal epithelial cultures.	17-allylamino-demethoxygeldanamycin	26-61	heat shock protein 86, pseudogene 1	Mus musculus	10-15	
27659253-3	2017	Here, effects of the Hsp90 blocker 17-allylamino-demethoxygeldanamycin (17AAG) applied topically to the skin were determined in experimental inflammatory epidermolysis bullosa acquisita (EBA), an anti-type VII collagen autoantibody-induced blistering skin disease.	17-allylamino-demethoxygeldanamycin	35-70	heat shock protein 86, pseudogene 1	Mus musculus	21-26